UBS Group AG Buys 236,152 Shares of Aveanna Healthcare Holdings Inc. $AVAH

UBS Group AG boosted its stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 149.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 394,182 shares of the company’s stock after acquiring an additional 236,152 shares during the period. UBS Group AG owned 0.19% of Aveanna Healthcare worth $3,220,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Teacher Retirement System of Texas boosted its holdings in shares of Aveanna Healthcare by 232.8% during the 3rd quarter. Teacher Retirement System of Texas now owns 224,375 shares of the company’s stock worth $1,990,000 after buying an additional 156,947 shares in the last quarter. AustralianSuper Pty Ltd bought a new position in shares of Aveanna Healthcare during the 3rd quarter worth approximately $15,743,000. Hillsdale Investment Management Inc. bought a new position in shares of Aveanna Healthcare during the 3rd quarter worth approximately $7,922,000. Vanguard Group Inc. boosted its holdings in shares of Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after buying an additional 1,535,351 shares in the last quarter. Finally, Algert Global LLC boosted its holdings in shares of Aveanna Healthcare by 120.1% during the 3rd quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock worth $9,070,000 after buying an additional 557,898 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider Patrick A. Cunningham sold 125,000 shares of the stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total value of $948,750.00. Following the transaction, the insider directly owned 212,755 shares in the company, valued at $1,614,810.45. This trade represents a 37.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 5.30% of the stock is currently owned by corporate insiders.

Aveanna Healthcare Price Performance

Shares of AVAH opened at $7.33 on Monday. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.73 and a 12-month high of $10.32. The business’s fifty day moving average is $6.75 and its 200 day moving average is $7.84. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The stock has a market cap of $1.60 billion, a P/E ratio of 6.21, a P/E/G ratio of 0.87 and a beta of 1.93.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company had revenue of $647.92 million for the quarter, compared to analysts’ expectations of $613.22 million. The firm’s quarterly revenue was up 15.9% on a year-over-year basis. Sell-side analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.56 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on AVAH shares. Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a report on Friday, March 20th. Royal Bank Of Canada increased their price target on Aveanna Healthcare from $9.00 to $10.00 and gave the stock a “sector perform” rating in a report on Friday, May 15th. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $10.00 to $11.00 in a report on Friday, May 15th. Barclays cut their price target on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a report on Monday, May 18th. Finally, Weiss Ratings cut Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.